Advancing Clinical Science | Accelerating Drug Discovery | Transforming Health with Integrity and Innovation

Clinical Trials

Discover the groundbreaking studies we are currently managing or participating in.

Study One

mAnaging siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE) Study

Principal Investigators

Emmanuel Peprah, PhD

Obiageli Nnodu, MD

Sponsor

NIH (National Institute of Health, USA)

Study Type

Pragmatic Implementation Study

iCTS Role

Trial Monitor

Sites

16 sites across Nigeria

Primary Objective

To evaluate the level of hydroxyurea (HU) adoption among healthcare providers of our task-sharing (SIM) intervention in Nigeria and determine if HU adoption improved patient-level Sickle Cell Disease management and outcomes.